A new drug called Tezspire has been approved by the Food and Drug Administration (FDA) to treat severe asthma. This is great news for people who struggle with severe asthma attacks despite using their regular asthma medicines.
Tezspire is different from other asthma drugs because it targets a specific part of the immune system that plays a key role in causing asthma symptoms. It is given as an injection under the skin every four weeks by a healthcare professional.
The FDA’s approval is based on successful clinical trials where Tezspire significantly reduced the number of severe asthma attacks and improved lung function in patients. Common side effects were minor and included sore throat, back pain, and injection site reactions.
This new treatment option is exciting for patients with severe asthma who have limited choices for managing their condition effectively. It is expected to be available soon, offering hope for better control of asthma symptoms and a higher quality of life for those affected.